NCT05550506 is a clinical trial of Duloxetine in Chronic Pain, sponsored by Cukurova University.

Who is sponsoring NCT05550506?

NCT05550506 is sponsored by Cukurova University.

What drugs are being tested in NCT05550506?

Interventions in NCT05550506: Duloxetine.

What condition does NCT05550506 study?

NCT05550506 studies Chronic Pain, Fibromyalgia.

Is NCT05550506 still recruiting?

NCT05550506 is currently status unknown. Last updated 22 September 2022.

Last reviewed 2022-09-22 · How we verify

NCT05550506

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Duloxetine on Bone Metabolism

Status unknown Last updated 22 September 2022

What this trial tests

trial testing Duloxetine in Chronic Pain in 102 participants. Status unknown.

Timeline

27 July 2022

Primary endpoint
1 October 2022

25 December 2022

Quick facts

Lead sponsor	Cukurova University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	102
Start date	27 July 2022
Primary completion	1 October 2022
Estimated completion	25 December 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Duloxetine (duloxetine) — full drug profile →

Conditions studied

Chronic Pain — all drugs for Chronic Pain →
Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Cukurova University

Who can join

Adults 18 to 50, any sex, with Chronic Pain or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to determine the effect of duloxetine as monotherapy on biochemical markers and bone mineral density.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Duloxetine

Trials testing the same drug.

NCT07431606 — Duloxetine in Inflammatory Bowel Diseases · Phase 2 · not yet recruiting
NCT07326163 — The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients · NA · enrolling by invitation
NCT06860984 — Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatograph · Phase 3 · recruiting
NCT06807866 — Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT · Phase 4 · recruiting
NCT06711978 — Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a R · NA · not yet recruiting

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Cukurova University trials

Trials by the same sponsor.

NCT07464652 — Objectıve Structured Clınıcal Examınatıon Stress For Intravenous Perıpheral Catheterızatıon · NA · not yet recruiting
NCT07458789 — Breastfeeding Education · NA · not yet recruiting
NCT07346482 — Determining the Effect of Midwife-Led Safe Infant Care Training for Pregnant Women on Awareness of Sudden Infant Death S · NA · not yet recruiting
NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea · NA · recruiting
NCT07241949 — Regional Analgesia Techniques for Laparoscopic Cholecystectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05550506 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cukurova University
Last refreshed: 22 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05550506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing